Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2019
Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options
Philipp Jurmeister, Claudia Vollbrecht, Anke Behnke, et al.
Science Translational Medicine
|
September 13, 2019
Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases
Philipp Jurmeister, Michael Bockmayr, Philipp Seegerer, et al.
The Journal of Pathology. Clinical Research
|
November 12, 2020
TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms
Maren Schmiester, Anna Dolnik, Uwe Kornak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2020
<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial
Marianne Sinn, Bruno V Sinn, Denise Treue, et al.
International Journal of Cancer
|
May 30, 2020
Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC
Clemens Messerschmidt, Benedikt Obermayer, Konrad Klinghammer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer
Bruno V Sinn, Sibylle Loibl, Claus A Hanusch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials
Paul Jank, Thomas Karn, Marion van Mackelenbergh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial
Sibylle Loibl, Denise Treue, Jan Budczies, et al.
NPJ Breast Cancer
|
April 13, 2026
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer
Marion T Van Mackelenbergh, Nicole Pfarr, Karsten Weber, et al.
Cancer Gene Therapy
|
June 8, 2024
Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemia
Liliana H Mochmann, Denise Treue, Michael Bockmayr, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2019
Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options
Philipp Jurmeister, Claudia Vollbrecht, Anke Behnke, et al.
Science Translational Medicine
|
September 13, 2019
Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases
Philipp Jurmeister, Michael Bockmayr, Philipp Seegerer, et al.
The Journal of Pathology. Clinical Research
|
November 12, 2020
TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms
Maren Schmiester, Anna Dolnik, Uwe Kornak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2020
<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial
Marianne Sinn, Bruno V Sinn, Denise Treue, et al.
International Journal of Cancer
|
May 30, 2020
Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC
Clemens Messerschmidt, Benedikt Obermayer, Konrad Klinghammer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer
Bruno V Sinn, Sibylle Loibl, Claus A Hanusch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials
Paul Jank, Thomas Karn, Marion van Mackelenbergh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2019
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial
Sibylle Loibl, Denise Treue, Jan Budczies, et al.
NPJ Breast Cancer
|
April 13, 2026
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer
Marion T Van Mackelenbergh, Nicole Pfarr, Karsten Weber, et al.
Cancer Gene Therapy
|
June 8, 2024
Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemia
Liliana H Mochmann, Denise Treue, Michael Bockmayr, et al.
Page
of 3